https://platform.ontopharmatech.com/monitoring 2026-07-16 hourly 1.0 https://platform.ontopharmatech.com/pricing 2026-07-16 monthly 0.7 https://platform.ontopharmatech.com/mcp-connect 2026-07-16 monthly 0.7 https://platform.ontopharmatech.com/privacy 2026-07-16 yearly 0.3 https://platform.ontopharmatech.com/terms 2026-07-16 yearly 0.3 https://platform.ontopharmatech.com/news/merck-wins-first-approval-of-a-pcsk9-cholesterol-pill-a831f172 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-20-non-pharmacovigilance-procedures-04550cd4 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-13-referral-procedures-93bf6ee1 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/solar-gi-b13718f6 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/philips-allura-xper-fd-series-4765e77f 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/cardiac-workstation-3ce78f9e 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-delivers-record-performance-as-2025-26-annual-report-and-accounts-confirms--73131639 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-29-4-referral-procedures-cd9bf689 2026-07-16 monthly 0.6 https://platform.ontopharmatech.com/news/celcuity-gains-fda-approval-for-closely-watched-breast-cancer-drug-e4d71211 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/merck-adc-in-china-study-shows-potential-to-replace-chemo-in-lung-cancer-f88dc991 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/braveheart-attovia-join-next-wave-of-biotech-ipos-7d1e0aef 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-30-referral-procedures-d152ec70 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/new-information-relating-to-s-9d-1-applications-for-listed-medicines-62aff2aa 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/updated-warnings-for-botulinum-toxin-products-following-rare-cases-of-botulism-2b48c48a 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-article-31-non-pharmacovigilance-referrals-f9d39dd0 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/j-j-dips-despite-upbeat-outlook-astrazeneca-spero-cut-china-deals-3e5491a8 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/botulinum-toxin-type-a-products-updated-warnings-regarding-risk-of-iatrogenic-bo-97400d5b 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-52-6b91459d 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/205-2026-5-2026-55-d47a1245 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/3-10-2026-56-03d4ba33 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-50-78487fd6 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-21-6868478a 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-62-a32b8155 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-58-8d5cfb52 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/2026-63-d9b676f9 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/new-who-guidelines-up-to-45-of-dementia-risk-could-be-prevented-or-delayed-3b995473 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-medical-devices-list-of-uk-approved-bodies-9971b358 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/leoni-plus-b64dfc89 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/presource-kits-containing-teleflex-pilling-wecksorb-neurosponge-c1194b3e 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-clinical-trials-regulations-transitional-arrangeme-fdb699bb 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/ema-and-eismea-boost-cooperation-to-accelerate-health-innovations-4101ca55 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-collection-verification-and-reporting-of-safety-ev-faa5c03a 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-medicines-and-healthcare-products-regulatory-agency-annual-repo-f548289b 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/draft-reflection-paper-on-particulars-for-safety-signals-for-traditional-herbal--737d16b3 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/executive-director-emer-cooke-s-speech-at-the-european-parliament-s-committee-on-256814a0 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guidelines-on-good-manufacturing-practice-f-13b6efbe 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guidelines-on-good-manufacturing-practice-f-7aca7f13 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/list-of-substances-and-products-subject-to-worksharing-for-signal-management-f6627342 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/global-childhood-immunization-coverage-inches-forward-despite-conflict-and-hesit-2a8a7147 2026-07-15 monthly 0.6 https://platform.ontopharmatech.com/news/cvs-caremark-reaches-settlement-with-ftc-over-insulin-suit-1891fb4b 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/judge-orders-apple-tree-partner-to-forfeit-oversight-of-venture-fund-1e862a40 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/fresh-off-buyout-akero-execs-reunite-to-advance-long-acting-psoriasis-pill-4897d7cf 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-international-recognition-procedure-88be4f48 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-privacy-no-f44e99d4 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/draig-bags-another-65m-to-speed-testing-of-brain-drugs-d036266e 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/biogen-data-highlight-promise-questions-surrounding-tau-targeting-alzheimer-s-dr-dc0b0cd6 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/37-2026-57-cf1ef3fb 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/2-2026-24-2aeab6a4 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/2026-25-3c11f7b1 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-6-to-10-july-2026-3712427d 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-in-vitro-diagnostic-point-of-care-test-devices-bf184c57 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/semaglutide-and-flextouch-solution-for-injection-in-pre-filled-pen-product-speci-3b681662 2026-07-14 monthly 0.6 https://platform.ontopharmatech.com/news/freenome-colorectal-cancer-test-data-improve-on-earlier-results-86d161aa 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/q32-bounces-back-to-claim-study-success-for-alopecia-drug-5ca0d715 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/agenus-surges-on-study-pivot-apnimed-lines-up-an-ipo-d7d39388 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/register-to-make-submissions-to-the-mhra-fe159bc7 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-beckton-dickson-uk-ltd-chloraprep-1ml-applicator-el-26--c975b7eb 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/oribe-serene-scalp-densifying-shampoo-presence-of-bacterial-contamination-5d75bcd2 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/apo-tiotropium-capsules-out-of-specification-particle-size-0f87a4ac 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/bd-chloraprep-clear-1ml-applicator-product-sterility-350f3fdb 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/biotech-startup-funding-gap-widens-despite-rebound-in-vc-investment-78b14dc6 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/pre-notification-check-for-type-ib-variations-eeb4b453 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-applicants-for-the-preparation-of-the-precise-scope-section-of-the--e3ca7ab1 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/el-salvador-validated-by-who-as-having-eliminated-trachoma-as-a-public-health-pr-e7f34ed3 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-c-a2c9b537 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-pre-authorisation-procedural-advice-for-users-of-the-c-00254986 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-on-good-manufacturing-practice-and-good-distribution-practice-questions-e2add771 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-post-authorisation-procedural-advice-for-users-of-the--0fad13b1 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/european-medicines-agency-post-authorisation-procedural-advice-for-users-of-the--2d51db3d 2026-07-13 monthly 0.6 https://platform.ontopharmatech.com/news/podcast-from-protocol-to-patient-inside-clinical-supply-with-almac-clinical-serv-ab58f659 2026-07-12 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-hansoh-adc-extends-survival-in-lung-cancer-study-ea0349c9 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/yellow-cards-bad-in-football-brilliant-in-patient-safety-3093a769 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/arpa-h-puts-160m-into-bespoke-drug-therapies-biohaven-switches-up-scientific-lea-23456bc7 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-6-9-b0c1eb02 2026-07-10 monthly 0.6 https://platform.ontopharmatech.com/news/roche-scraps-two-ionis-partnered-huntington-s-drugs-082d3834 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/gsk-ends-brain-drug-alliance-with-alector-f17cfe09 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/access-new-active-substance-and-biosimilar-work-sharing-initiatives-32c605d0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/hhs-plan-to-speed-drug-research-won-t-remove-self-inflicted-delays-d8cdb0a2 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/astral-150-66781c5c 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/m-warmer-10fe2a0d 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/phantom-hindfoot-ttc-tc-ball-tipped-guide-rod-18cca565 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/research-use-of-uk-plasma-for-the-manufacture-of-five-further-plasma-derived-med-ba4113ae 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/astrazeneca-ionis-drug-fails-big-heart-disease-study-in-major-setback-29698a2b 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/heat-travel-and-late-nights-how-summer-can-affect-your-medicines-and-how-to-stay-b752c927 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-review-gives-uk-plasma-donations-go-ahead-1e10d46f 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-bristol-laboratories-limited-phenoxymethylpenicillin-25-7a45bc66 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-9860de94 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-d60a3d23 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-35c64cda 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-c5285b02 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/instituto-de-salud-p-blica-de-chile-9124aedb 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/disposiciones-para-la-adquisici-n-y-fabricaci-n-de-ventiladores-durante-la-emerg-fccde067 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/comunicado-a-la-poblaci-n-comisi-n-federal-para-la-protecci-n-contra-riesgos-san-dae259f2 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cofepris-establece-nuevo-sistema-electr-nico-de-citas-comisi-n-federal-para-la-p-a67cee99 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cofepris-elimina-barreras-para-la-producci-n-de-medicamentos-gen-ricos-comisi-n--56679ab6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cofepris-informa-sobre-la-autorizaci-n-de-pruebas-serol-gicas-comisi-n-federal-p-1e2be072 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/funci-n-p-blica-y-cofepris-colaboran-para-rescatar-de-intereses-privados-el-sect-d68079d8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/renuevan-m-xico-y-estados-unidos-alianza-por-la-inocuidad-alimentaria-comisi-n-f-d0a7ef47 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nuevo-mecanismo-para-fortalecer-el-mercado-de-medicamentos-gen-ricos-comisi-n-fe-90352341 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/news-ef38e5b8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/news-bed7baac 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/china-nmpa-and-singapore-hsa-sign-mou-on-regulatory-cooperation-211507d4 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-commissioner-meets-who-representative-for-enhanced-collaboration-bb0e86e4 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/china-updates-drug-clinical-trial-guideline-to-enhance-biotech-innovation-851cdeb6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-deputy-commissioner-meets-australian-ambassador-to-discuss-medical-product--3a7ef639 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-deputy-commissioner-meets-with-danish-ambassador-and-novo-nordisk-chairman-5a2ae1c1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/nmpa-meeting-on-vaccine-regulatory-qms-and-who-wla-assessment-0bc54fa9 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/ixchiq-chikungunya-vaccine-temporary-suspension-in-people-aged-65-years-or-older-b072d14d 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-determina-apreens-o-de-saneantes-sem-registro-ag-ncia-nacional-de-vigil-n-5faf7298 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-atualiza-listas-de-subst-ncias-para-uso-em-cosm-ticos-ag-ncia-nacional-de-018071e1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/canais-de-divulga-o-da-anvisa-ser-o-ajustados-durante-per-odo-do-defeso-eleitora-4419f10e 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/entram-em-vigor-os-novos-comp-ndios-da-farmacopeia-brasileira-ag-ncia-nacional-d-1a87224a 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-disponibiliza-nova-ferramenta-para-consulta-de-alertas-sanit-rios-ag-ncia-7d84ab68 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-aprova-nova-indica-o-terap-utica-para-medicamento-que-trata-c-ncer-de-mam-2440267c 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/canetas-do-paraguai-n-o-demonstraram-equival-ncia-com-medicamentos-registrados-n-b3426100 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/anvisa-realiza-12-reuni-o-ordin-ria-p-blica-da-diretoria-colegiada-ag-ncia-nacio-dc545de5 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-prescribing-medicines-in-pregnancy-database-may-2026-additions-and-a-907778fe 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/lapse-of-provisional-registration-for-andexxa-andexanet-alfa-in-australia-be9bce7a 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-authorised-prescriber-scheme-for-mdma-and-psilocybine-access-6fb0a611 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-permissible-ingredients-for-listed-medicines-in-june-2026-b9409d21 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-updates-listed-medicine-compliance-reports-for-june-2026-cancelling-8-medici-c01d10b1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/australia-new-udi-requirements-for-medical-devices-commence-1-july-2026-fc5b1359 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/news-articles-therapeutic-goods-administration-tga-40bfb8d8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/your-request-has-been-blocked-security-incident-8fe85aa8 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/tga-news-articles-regulatory-updates-and-compliance-for-pharma-8a4e38b0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/finasteride-and-dutasteride-updated-safety-warnings-for-psychiatric-side-effects-4902006d 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/hormone-replacement-therapy-hrt-further-information-on-the-known-increased-risk--9fb9ef9e 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/adrenaline-auto-injectors-aais-new-guidance-and-resources-for-safe-use-gov-uk-24263316 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/ondansetron-for-intravenous-use-dose-dependent-qt-interval-prolongation-gov-uk-e567eb10 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/ace-inhibitors-and-angiotensin-ii-receptor-antagonists-not-for-use-in-pregnancy--1376d2b9 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/carbapenems-concomitant-use-with-valproic-acid-not-recommended-gov-uk-c73da8c0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/sitaxentan-thelin-worldwide-withdrawal-from-the-market-gov-uk-0e3051ec 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2023-gov-0023c040 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia-gov-uk-57268ff6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/part-11-electronic-records-electronic-signatures-scope-and-application-fda-03d25182 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/safety-efficacy-and-pharmacokinetic-studies-to-support-marketing-of-immune-globu-3966b2c0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/premarketing-risk-assessment-fda-47cd8264 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cancer-clinical-trial-eligibility-criteria-washout-periods-and-concomitant-medic-606dfb22 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/pulse-oximeters-for-medical-purposes-non-clinical-and-clinical-performance-testi-85f582d1 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/frequently-asked-questions-statement-of-investigator-form-fda-1572-fda-c4ecf0e0 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/redbook-2000-iv-c-4-a-subchronic-toxicity-studies-with-rodents-fda-8769b6c6 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/q2a-text-on-validation-of-analytical-procedures-fda-8dfba1d2 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/cpg-sec-562-750-labeling-of-food-articles-distributed-solely-in-puerto-rico-fda-8aedcf24 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/a-risk-based-approach-to-monitoring-of-clinical-investigations-questions-and-ans-0e0edf67 2026-07-09 monthly 0.6 https://platform.ontopharmatech.com/news/astrazeneca-gsk-intensify-china-ties-with-sino-biopharm-deals-b74d52f4 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/four-sentenced-to-nearly-15-years-combined-jail-time-following-major-mhra-invest-debdf851 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/health-regulators-warn-against-the-use-or-dispensing-of-recalled-semaglutide-and-f90fecb6 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/prime-wins-gene-editing-dispute-saol-claims-latest-post-makary-fda-reversal-e6d2e552 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/two-lots-of-omnitrope-injectable-human-growth-hormone-recalled-due-to-cracked-ca-32051eca 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/alice-le-system-sleepware-software-29c949c3 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/allura-xper-fd10-c1b5f827 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/who-calls-for-urgent-action-as-new-cancer-cases-are-projected-to-nearly-double-b-53d29eeb 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/policy-paper-medicines-and-healthcare-products-regulatory-agency-mhra-economic-g-c2014aed 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/nerandomilast-jascayd-approved-to-treat-adult-patients-with-idiopathic-pulmonary-35c1553d 2026-07-08 monthly 0.6 https://platform.ontopharmatech.com/news/oberland-pours-up-to-400m-into-meiragtx-eye-gene-therapies-aa3ddc76 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/kailera-says-obesity-pill-succeeds-in-late-stage-trial-in-china-bb3affe1 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/take-control-of-your-learning-journey-and-understand-your-regulatory-obligations-543598db 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/vertex-to-acquire-crinetics-in-10b-foray-into-endocrine-disease-drugs-982e0ff6 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/ema-fast-tracks-review-of-a-medicine-for-metastatic-pancreatic-cancer-59555ac6 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/vera-therapeutics-wins-fda-nod-for-closely-watched-kidney-disease-drug-068e45d6 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-29-june-to-03-july-2026-630712a4 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/decision-advertising-investigations-june-2026-b6cf1782 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-clinical-trials-for-medicines-roles-and-responsibilities-9e4cb73c 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/decision-doxecitine-and-doxribtimine-in-the-treatment-of-thymidine-kinase-2-defi-2e7e6e03 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/qualification-of-novel-methodologies-for-medicinal-product-development-guidance--4d70508e 2026-07-07 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-ending-a-clinical-trial-dcb6e031 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/gene-editing-developer-scribe-plots-an-ipo-b21485c1 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/novartis-to-acquire-adc-developer-in-a-deal-worth-up-to-1-5b-f5821ed4 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/cancer-immune-drugmakers-dominate-vc-funding-so-far-in-2026-414be83a 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/beyond-boston-unlikely-cities-stake-biotech-claims-b32bd12c 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/hotline-iv-fluid-warmer-system-accessories-7dbc6e41 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-mhra-innovation-office-e532675e 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-approves-retifanlimab-zynyz-for-the-treatment-of-advanced-merkel-cell-skin--e7402a7c 2026-07-06 monthly 0.6 https://platform.ontopharmatech.com/news/semaglutide-wegovy-approved-to-treat-form-of-liver-disease-435d3753 2026-07-03 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-best-practice-in-the-labelling-and-packaging-of-medicines-a2a6e1c7 2026-07-03 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-submit-changes-to-labels-and-patient-information-leaflets-as-a-self-cer-182970ff 2026-07-03 monthly 0.6 https://platform.ontopharmatech.com/news/classification-of-products-as-drugs-and-devices-and-additional-product-classific-46f3ee44 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/expanded-access-to-investigational-drugs-for-treatment-use-questions-and-answers-309fd289 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/cpg-sec-540-600-fish-shellfish-crustaceans-and-other-aquatic-animals-fresh-froze-34e69652 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/e11a-pediatric-extrapolation-fda-e43b6d10 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/study-of-sex-differences-in-the-clinical-evaluation-of-medical-products-fda-a5abac6e 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/cvm-gfi-224-vich-gl52-bioequivalence-blood-level-bioequivalence-study-fda-306833a2 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/prevention-and-treatment-of-chemotherapy-induced-peripheral-neuropathy-developin-8ea0bfc7 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/fda-alerts-health-care-providers-to-cases-of-neurologic-complications-from-gener-0ae10d8f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/drug-alerts-and-statements-2ea72e81 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/fda-listing-of-authorized-generics-e542369b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drug-user-fee-amendments-83ceaf3d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/patent-certifications-and-suitability-petitions-16a6e27b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/who-adds-first-diagnostic-test-for-ebola-bundibugyo-virus-to-its-emergency-use-l-bf6a9e98 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/medicines-apply-for-a-variation-to-your-marketing-authorisation-09220a1d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/patient-education-bd88d69b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/a-puretech-startup-banks-180m-for-a-new-ipf-drug-8c97ddaf 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-medicines-that-you-cannot-export-from-the-uk-or-hoard-a146c3d1 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/roche-kras-drug-succeeds-in-head-to-head-lung-cancer-study-64812043 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/making-regulation-a-catalyst-not-a-barrier-for-uk-life-sciences-1298ad81 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/preventing-accidental-apoquel-chewable-overdoses-629f6869 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/ema-steps-up-efforts-on-medicines-for-women-s-health-325908ec 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/competitive-generic-therapy-approvals-0891aec4 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/patient-enrolment-begins-in-a-scientific-trial-to-identify-the-first-effective-t-7cf3e3e0 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/lifecodes-lsa-class-ii-1307d65b 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/nephromax-high-pressure-nephrostomy-balloon-catheter-0f9fc7db 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/fludeoxyglucose-18f-injection-cracket-vial-38c4c3b1 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/wasplab-5a00a7b9 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/research-mhra-data-requirements-to-support-regulatory-decision-making-412cb97a 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/borderline-products-how-to-tell-if-your-product-is-a-medicine-e9e0499f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/redbook-2000-iv-c-3-b-short-term-toxicity-studies-with-non-rodents-fda-bbabacd5 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/falsified-mounjaro-kwikpen-15mg-pre-filled-pens-gov-uk-11e9e574 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/heart-pump-recall-abiomed-removes-impella-cp-sets-with-smartassist-19bf2b55 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/insulin-pump-recall-insulet-removes-omnipod-pods-22438a54 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/breathing-circuit-set-correction-hamilton-medical-updates-use-instructions-for-b-3eaebdf7 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/transdermal-fentanyl-patches-for-non-cancer-pain-do-not-use-in-opioid-naive-pati-f0433a76 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/idelalisib-zydelig-updated-indications-and-advice-on-minimising-the-risk-of-infe-a4c8692d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/prolonged-release-opioids-removal-of-indication-for-relief-of-post-operative-pai-1bc0e2af 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/covid-19-vaccines-and-medicines-updates-for-february-2022-gov-uk-bba1883e 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/improving-information-supplied-with-gabapentinoids-pregabalin-gabapentin-benzodi-1122bb2f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/benzodiazepines-and-opioids-reminder-of-risk-of-potentially-fatal-respiratory-de-e369b2c3 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/5-fluorouracil-intravenous-capecitabine-tegafur-dpd-testing-recommended-before-i-e7120bf5 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/domperidone-for-nausea-and-vomiting-lack-of-efficacy-in-children-reminder-of-con-8b789b1f 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/the-black-triangle-scheme-or-gov-uk-bff7a3f2 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/covid-19-vaccines-and-medicines-updates-for-february-2021-gov-uk-1ff4af80 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/adrenaline-auto-injector-advice-for-patients-gov-uk-8d15d6e0 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/nasal-decongestant-sprays-and-drops-containing-xylometazoline-hydrochloride-oxym-f1270d1d 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/report-misleading-medicines-advertisements-gov-uk-6e6d1777 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/q1b-photostability-testing-of-new-drug-substances-and-products-fda-8289263e 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/draft-guidance-for-industry-labeling-of-plant-based-milk-alternatives-and-volunt-c40c5457 2026-07-02 monthly 0.6 https://platform.ontopharmatech.com/news/emergency-use-authorizations-for-drugs-and-non-vaccine-biological-products-82eebd87 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/coronavirus-covid-19-drugs-9a32956e 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-first-gene-therapy-for-young-children-with-sickle-cell-disease-af816308 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/kao-usa-voluntarily-recalls-some-lots-of-oribe-serene-scalp-densifying-shampoo-dd916e0b 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/what-s-new-related-to-drugs-584370cd 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/magnum-brand-products-may-be-harmful-due-to-hidden-drug-ingredients-3117714e 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/sexual-enhancement-and-energy-product-notifications-cbccfa41 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/eunha-fisheries-co-ltd-issues-allergy-alert-on-undeclared-wheat-soy-and-sesame-i-9aafefc7 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/data-standards-program-strategic-plan-and-board-caae736a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/cder-data-standards-program-596af54f 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/cder-quality-management-maturity-4861f3e1 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/bridgebio-gets-funding-for-drug-launch-united-buys-into-cell-therapy-62563323 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/untitled-letters-e1f02e26 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/generic-drug-facilities-sites-and-organization-lists-881bd82a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/newly-added-guidance-documents-475396f1 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/submitting-next-generation-sequencing-data-to-the-division-of-antiviral-products-2989ed36 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/medicines-packaging-labelling-and-patient-information-leaflets-a25c4379 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-warning-statements-for-labels-and-leaflets-of-certain-medicines-2ac85d38 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-best-practice-guidance-on-patient-information-leaflets-0ff663f8 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/drugs-fda-data-files-7de0cc08 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/ipsen-to-buy-swiss-biotech-memo-therapeutics-in-potential-800m-deal-1276303a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-authorises-gemcitabine-delivery-system-for-adults-with-bcg-unresponsive-hig-7c6874c3 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/5-fda-decisions-to-watch-in-the-third-quarter-of-2026-405b368b 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/financial-transparency-and-efficiency-of-the-prescription-drug-user-fee-act-bios-fc2b03f8 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/abivax-shares-surge-as-worries-subside-over-immune-drug-s-cancer-risk-be1bf1cb 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/table-of-decisions-of-labelling-exemption-requests-falling-under-article-63-of-d-95bfb20d 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/reviews-of-pediatric-studies-conducted-under-bpca-and-pediatric-assessments-cond-a8404542 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/q8-q9-q10-questions-and-answers-appendix-q-as-from-training-sessions-q8-q9-q10-p-9a6d3d98 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/crohn-s-disease-developing-drugs-for-treatment-fda-a5dafd0a 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/enhancing-participation-in-clinical-trials-eligibility-criteria-enrollment-pract-defc1ded 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/cvm-gfi-252-small-entity-compliance-guide-antimicrobial-animal-drug-sales-and-di-04b346d2 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/design-and-analysis-of-shedding-studies-for-virus-or-bacteria-based-gene-therapy-4ee1dfc7 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/interacting-with-the-fda-on-complex-innovative-trial-designs-for-drugs-and-biolo-78cfaf64 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/patient-focused-drug-development-incorporating-clinical-outcome-assessments-into-8a984df2 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/s1a-the-need-for-long-term-rodent-carcinogenicity-studies-of-pharmaceuticals-fda-d9dc7a3e 2026-07-01 monthly 0.6 https://platform.ontopharmatech.com/news/pharmacy-compounding-advisory-committee-roster-38f9fceb 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/oncology-cancer-hematologic-malignancies-approval-notifications-808577ee 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-allogeneic-regulatory-t-cell-based-immunotherapy-with-hspc-and-t-ce-c8d34da5 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-new-treatment-that-uses-donor-immune-cells-to-prevent-serious-compl-776a9aa7 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/ipsen-s-450m-blood-cancer-drug-fda-selects-first-cohort-for-pre-check-pilot-prog-32110501 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/january-march-2026-new-safety-information-or-potential-signals-of-serious-risks--935fbde1 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/new-safety-information-or-potential-signals-of-serious-risks-identified-from-the-579a177e 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/viridian-may-have-edge-over-amgen-in-eye-drug-showdown-analysts-argue-02a3c9ab 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-22-to-26-june-2026-5ee53b79 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/these-biotechs-just-landed-big-fundraising-hauls-here-s-what-they-pitched-to-inv-bca6e69f 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/beeline-ups-its-series-a-round-for-immune-drug-work-848a19e5 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/top-fda-gene-and-cell-therapy-regulator-to-step-down-8f969c79 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-roundup-june-2026-d6a9d3bb 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/class-3-medicines-recall-flamingo-pharma-uk-ltd-flucloxacillin-capsules-bp-500mg-6e855f7a 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-relonchem-limited-gabapentin-relonchem-50m-8d01c66c 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/institutional-review-boards-frequently-asked-questions-fda-49b88b9b 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/use-of-international-standard-iso-10993-1-biological-evaluation-of-medical-devic-8cd18637 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/leveraging-prior-knowledge-in-the-development-of-human-gene-therapy-products-inc-a3229ef6 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/bioavailability-and-bioequivalence-studies-for-nasal-aerosols-and-nasal-sprays-f-a9064166 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/pharmacokinetics-in-patients-with-impaired-hepatic-function-study-design-data-an-97281f37 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/new-and-revised-draft-q-as-on-biosimilar-development-and-the-bpci-act-revision-4-af868f4f 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/safety-assessment-of-genome-editing-in-human-gene-therapy-products-using-next-ge-72054329 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-substantiation-for-dietary-supplement-claims-made-under-se-1057ed04 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/study-data-technical-conformance-guide-technical-specifications-document-fda-57fbab94 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/considering-whether-an-fda-regulated-product-involves-the-application-of-nanotec-51059fab 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/small-entity-compliance-guide-current-good-manufacturing-practice-in-manufacturi-4b4932ac 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/implantable-marker-recall-hologic-removes-biozorb-3d-bioabsorbable-markers-due-t-42373b17 2026-06-30 monthly 0.6 https://platform.ontopharmatech.com/news/fda-selects-seven-participants-for-precheck-pilot-program-to-advance-u-s-drug-ma-952ba2d0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-borderline-products-medical-devices-and-other-products-8ccb23e3 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-innovation-accelerator-5fbf6f8c 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-mhra-innovation-accelerator-d1c033c4 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/theravance-after-clinical-setbacks-agrees-to-929m-buyout-ffc0bb23 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trial-considerations-to-support-accelerated-approval-of-oncology-therap-b2d15bc3 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/content-and-format-of-premarket-notification-510-k-submissions-for-liquid-chemic-8f1b7197 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/q8-q9-and-q10-questions-and-answers-r5-fda-2a993ad9 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/abiomed-introducer-kits-with-impella-heart-pumps-d8c59b8f 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/10-clinical-trials-to-watch-in-the-second-half-of-2026-d0a4b05b 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/orlistat-safety-update-gov-uk-ab1f3a2d 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/labeling-and-effectiveness-testing-sunscreen-drug-products-for-over-the-counter--08db5767 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/high-dose-cyproterone-acetate-potential-risk-of-multiple-meningiomas-gov-uk-006884f0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/cybersecurity-in-medical-devices-quality-management-system-considerations-and-co-720e92bf 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/information-requests-and-discipline-review-letters-under-the-generic-drug-user-f-f4a4ef38 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/considerations-for-the-use-of-artificial-intelligence-to-support-regulatory-deci-8dcd76d0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/letters-sent-to-healthcare-professionals-in-january-2016-gov-uk-c773ea6a 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/mesalazine-and-idiopathic-intracranial-hypertension-gov-uk-1034d6fb 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/vitamin-b12-hydroxocobalamin-cyanocobalamin-advise-patients-with-known-cobalt-al-d84d1af8 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/non-steroidal-anti-inflammatory-drugs-nsaids-potential-risks-following-prolonged-c52e8436 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/statins-interactions-and-updated-advice-for-atorvastatin-gov-uk-e3af92cc 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/reviewer-guidance-for-nebulizers-metered-dose-inhalers-spacers-and-actuators-fda-d71de1e0 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/supac-ss-nonsterile-semisolid-dosage-forms-scale-up-and-post-approval-changes-ch-84b22a4c 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/q14-analytical-procedure-development-fda-bef30c2e 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/q2-r2-validation-of-analytical-procedures-fda-71766f70 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/attention-deficit-hyperactivity-disorder-developing-stimulant-drugs-for-treatmen-14319ed8 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-action-levels-for-lead-in-processed-food-intended-for-babi-6b380305 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/marketing-submission-recommendations-for-a-predetermined-change-control-plan-for-8a16b190 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-brancaster-pharma-limited-benzylpenicillin-6dcb003d 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/simvastatin-increased-risk-of-myopathy-at-high-dose-80-mg-gov-uk-a3c703eb 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/temozolomide-risk-of-hepatic-injury-including-fatal-hepatic-failure-updated-warn-104e0781 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/intravenous-iron-and-serious-hypersensitivity-reactions-strengthened-recommendat-2fecdc50 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/levothyroxine-new-prescribing-advice-for-patients-who-experience-symptoms-on-swi-01e469d4 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/draft-guidance-for-industry-hazard-analysis-and-risk-based-preventive-controls-f-f0dab420 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/ingenol-mebutate-gel-picato-increased-incidence-of-skin-tumours-seen-in-some-cli-f2bcef0a 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-food-labeling-guide-fda-8efdda75 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/general-considerations-for-animal-studies-intended-to-evaluate-medical-devices-f-708a6463 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2022-gov-582296df 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-for-industry-the-seafood-list-fda-s-guide-to-determine-acceptable-seafo-d83e79f4 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/letters-and-drug-alerts-sent-to-healthcare-professionals-in-november-2020-gov-uk-841b9414 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/medical-device-alerts-issued-in-march-2018-gov-uk-bc1dec44 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/show-your-support-for-reporting-suspected-adverse-drug-reactions-gov-uk-a9a237f9 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/document-a097c753 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/u-s-food-and-drug-administration-24dc1aba 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-the-clinical-evaluation-of-ant-073a20f2 2026-06-29 monthly 0.6 https://platform.ontopharmatech.com/news/la-ceiba-foods-latin-market-inc-recalls-cottage-cheese-products-because-of-possi-f50e862a 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/total-nutrition-inc-recalls-organic-moringa-products-following-supplier-initiate-7f60dcc8 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/fda-accepts-replimune-filing-merck-kgaa-drops-11b-on-life-sciences-services-4576399b 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/at-bio-tension-over-china-biotech-deal-regulation-looms-0c58d81a 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-data-requirements-for-authoris-17899850 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-revision-of-the-guideline-on-data-requirements-for-the-repl-0439fb18 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/register-medical-devices-to-place-on-the-market-593f13cf 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/alkermes-incoming-ceo-has-a-plan-to-outplay-lilly-and-takeda-17d042ca 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/on-second-try-acadia-drug-gets-nod-from-european-regulators-db0a7be5 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/fda-proposes-rule-that-would-help-hold-foreign-tobacco-product-manufacturers-acc-f610d436 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/remifentanil-hydrochloride-for-injection-out-of-specification-assay-impurity-71a02afc 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--d5b1c9ac 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/first-aid-kit-recall-north-american-rescue-issues-correction-for-first-aid-kits--86991984 2026-06-26 monthly 0.6 https://platform.ontopharmatech.com/news/revival-animal-health-llc-voluntarily-recalls-canine-and-gm-milk-replacers-due-t-8fc154ce 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/lehi-valley-trading-company-issues-allergy-alert-on-undeclared-peanuts-in-chocol-1b70e70c 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/remix-to-go-public-in-reverse-merger-with-once-high-flying-passage-bio-a598bcce 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/antares-gets-105m-from-novartis-for-new-cancer-drugs-bda76880 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/bear-stewart-llc-issues-allergy-alert-on-undeclared-soy-in-bakr-brown-butter-cho-2c388826 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/protecting-patients-ensuring-safe-quality-and-effective-health-products-082e316e 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/spiriva-capsules-out-of-specification-uniformity-of-delivered-dose-5e2f0aa0 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-mhra-innovation-office-guidance-and-support-e1ebaa67 2026-06-25 monthly 0.6 https://platform.ontopharmatech.com/news/ionis-with-new-fda-nod-hits-a-commercial-inflection-point-81d56b9f 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/investors-pour-115m-into-rq-bio-in-search-of-a-preventive-flu-drug-34ca3277 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/to-wall-street-psychedelics-biotechs-are-more-teammates-than-rivals-24aee8af 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/notice-register-of-authorised-online-sellers-of-medicines-in-northern-ireland-f6d48fed 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/infinion-cx-contact-lead-kit-faa6091b 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/uhi-4-high-flow-insufflation-system-insufflator-6c3a3b87 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/argon-medical-devices-l-cath-picc-and-midline-catheters-455134e7 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/655-million-people-still-living-without-electricity-underscore-urgent-need-to-de-14cc57c1 2026-06-24 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-15-to-19-june-2026-8fcc061e 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/optima-xr240amx-x-ray-system-7bc1aa4b 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/a-t-s-4000-ts-tourniquet-systems-single-and-dual-hose-with-cpc-connectors-4251612b 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/hoffmann-ii-carbon-connecting-rod-f6e1e4c0 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/who-urges-scale-up-of-newborn-screening-to-improve-early-detection-and-care-of-b-30154a99 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/annex-22-expert-workshop-draft-agenda-day-1-session-with-interested-parties-05b2d1a2 2026-06-23 monthly 0.6 https://platform.ontopharmatech.com/news/penumbra-system-red-68-reperfusion-catheter-3c777a95 2026-06-22 monthly 0.6 https://platform.ontopharmatech.com/news/gyrus-acmi-classic-series-continuous-flow-resectoscope-5547f029 2026-06-22 monthly 0.6 https://platform.ontopharmatech.com/news/cyberknife-treatment-delivery-system-f5c6a317 2026-06-22 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-16--e0f143a8 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/bd-maxplus-connector-minibore-extension-set-bac730b0 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/faradrive-steerable-sheath-1684d579 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/update-on-the-pathways-clinical-trial-8f3ab389 2026-06-19 monthly 0.6 https://platform.ontopharmatech.com/news/warning-on-promoting-newly-licensed-prescription-only-medicines-and-unlicensed-m-a0e4959e 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/atellica-ch-enzymatic-hemoglobin-a1c-a1c-e-assay-3622a559 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/med-rx-wound-care-kit-55d6ff38 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-advice-for-consumers-1866cace 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-catheter-introducer-issue-from-abiomed-and-oscor-b44cdefd 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/catheter-recall-expansion-medline-industries-removes-reprocessed-electrophysiolo-c2bbcdcb 2026-06-18 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-covid-19-test-validation-approved-products-563bfe6e 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/polyflex-powder-for-suspension-cracked-vials-f9ff2a07 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/plum-precision-iv-pumps-32bf4719 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/single-use-distal-cover-68693bfe 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/artis-icono-ceiling-d3af4482 2026-06-17 monthly 0.6 https://platform.ontopharmatech.com/news/ace-inhibitors-be-aware-of-the-distinction-between-bradykinin-and-histamine-medi-12b93afd 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/lancora-tablets-broken-partial-tablets-in-blister-pack-59c83e7b 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/unauthorized-soft-shelled-hyperbaric-chambers-may-pose-serious-health-risks-2026-d5d184ae 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/ge-healthcare-integrated-and-stand-alone-resuscitation-systems-71237eee 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/class-3-medicines-recall-orbit-pharma-limited-cyclizine-lactate-50-mg-ml-solutio-7f90cc2e 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/committee-for-advanced-therapies-cat-rules-of-procedure-55bf4fa5 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-convenience-kit-issue-from-windstone-medical-packaging-inc-5303c45a 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/disruptions-in-availability-of-breast-biopsy-needles-letter-to-health-care-provi-9ea55e41 2026-06-16 monthly 0.6 https://platform.ontopharmatech.com/news/unique-liaison-programme-set-to-reinforce-close-collaboration-between-mhra-and-f-34a9ce7f 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-8-12-june-2026-4ca9dcb1 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/iris-guide-to-registration-and-rpis-8b62a3c5 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/iris-guide-for-applicants-how-to-create-submit-and-manage-iris-applications-for--6f8ded33 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/ema-management-board-highlights-of-june-2026-meeting-1d2467d4 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/anesthesia-machine-correction-draeger-inc-issues-correction-for-atlan-a350-and-a-64f1ea11 2026-06-15 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-scientific-leader-recognised-in-2026-king-s-birthday-honours-3cbeb358 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/lower-dose-needle-free-allergy-treatment-approved-for-younger-children-9ee6777f 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/products-management-services-pms-implementation-of-international-organization-fo-efb39cf9 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-pharmacovigilance-risk-assessment-committee-prac-8-1-c7cbf4de 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/convenience-kit-correction-medline-issues-correction-for-kits-containing-huons-b-cb0e0487 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/accolade-pacemaker-devices-by-boston-scientific-and-potential-need-for-early-dev-a759a90f 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/beekeeper-s-naturals-issues-voluntary-nationwide-recall-of-beekeeper-s-naturals--3f522cdc 2026-06-12 monthly 0.6 https://platform.ontopharmatech.com/news/first-glp-1-tablet-for-weight-loss-approved-in-the-uk-3765e19c 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-landmark-report-reveals-public-views-on-ai-in-healthcare-4619a0ad 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/regulation-of-medical-devices-in-northern-ireland-8f200ed4 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/contact-the-mhra-f18d19b8 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-the-impact-of-mutual-recognition-agreement-mra-between--d2b9ad60 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/etms-70-mm-cooled-coil-c1d5e744 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/aptima-hiv-quant-dx-assay-hcv-quant-dx-assay-and-hbv-quant-assay-software-fc04aa22 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/regulation-of-ai-in-healthcare-6809d5df 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/research-national-commission-into-the-regulation-of-ai-in-healthcare-research-en-519a8337 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/ema-s-2025-annual-report-shows-strong-approval-numbers-for-human-and-veterinary--2f6afafb 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/medical-devices-ask-for-a-regulatory-advice-meeting-from-the-mhra-a0c21f18 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-positive-pressure-breathing-device-issue-from-baxter-4bbd5345 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/heart-pump-correction-abiomed-issues-correction-for-automated-impella-controller-2bce4db7 2026-06-11 monthly 0.6 https://platform.ontopharmatech.com/news/fda-approves-labeling-changes-for-over-the-counter-otc-weight-loss-drug-alli-orl-94448cd6 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/selenia-dimensions-2d-3d-mammography-systems-6844ebba 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/nicotine-pouch-recall-no-market-authorization-4e120e8d 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/opportunities-for-patients-and-the-public-to-be-involved-in-the-work-of-the-mhra-b4b996db 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/pioneering-ai-health-innovations-regulatory-sandbox-launched-19698e29 2026-06-10 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-launches-ai-sandbox-to-accelerate-medicines-development-and-improve-safety-13a4cef5 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/nipocalimab-imaavy-authorised-to-treat-adults-and-adolescents-with-generalised-m-386b56fa 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/guedel-airway-34f9c069 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/promotional-material-national-ai-commission-ask-me-anything-817f4b03 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-ai-airlock-simulation-workshops-b22f22c3 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-ai-airlock-sandbox-phase-2-programme-report-937166ab 2026-06-09 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-advertising-investigations-may-2026-7776c6f0 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-trials-for-medicines-modifying-a-clinical-trial-approval-8af5aa07 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/pms-fluconazole-50-mg-tablets-incorrect-quantity-of-tablets-825bb41d 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/baxter-corporation-products-recall-blue-cap-breakage-8856751f 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-1-5-june-2026-d363db39 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-cadila-pharmaceuticals-limited-mirtazapine-9dda28bc 2026-06-08 monthly 0.6 https://platform.ontopharmatech.com/news/decision-human-and-veterinary-medicines-register-of-licensed-manufacturing-sites-7ab83885 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/notice-register-of-brokers-authorised-to-deal-in-human-medicines-f1236e9d 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/decision-medicines-new-manufacturing-and-wholesale-dealer-licences-acc36634 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/notice-medicines-terminated-and-cancelled-manufacturing-and-wholesale-dealer-lic-6a491726 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/decision-human-medicines-register-of-licensed-wholesale-distribution-sites-14233e64 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-review-of-the-benefits-and-risks-of-avacopan-b00cf505 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/find-product-information-about-medicines-64c4b7da 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/member-states-contact-points-for-translations-review-bb70c6f3 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/checklist-for-the-submission-of-day-215-product-information-annexes-for-a-post-o-2deea3f1 2026-06-05 monthly 0.6 https://platform.ontopharmatech.com/news/adjuvanted-trivalent-influenza-vaccine-authorised-for-adults-aged-50-and-over-3da1daae 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/research-mhra-public-sector-equality-duty-report-2025-2026-d2eb421b 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/harmony-delivery-catheter-system-a1637260 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/philips-allura-xper-systems-b868a9f4 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/giraffe-omnibed-carestation-2353ccb6 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/class-4-medicines-defect-notification-teva-uk-ltd-ponlimsi-denosumab-60mg-soluti-5eb80899 2026-06-04 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-strengthens-industry-collaboration-to-improve-access-to-safe-medicines-dc7a0973 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/resmetirom-rezdiffra-authorised-to-treat-metabolic-dysfunction-associated-steato-8518202c 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-development-of-a-reflection-paper-on-the-use-of-external-co-fa288631 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/ema-ama-and-african-regulatory-authorities-join-forces-on-ebola-outbreak-respons-1d696956 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/iceman-classic3-27f7652d 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/artis-icono-ceiling-floor-and-biplane-systems-91a69f19 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/dexcom-g7-sensor-1-pack-e005780b 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/intellicuff-fd685cbe 2026-06-03 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-becton-dickinson-uk-ltd-chloraprep-2-1ml-and-chloraprep-79d74fe1 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/kala-red-light-face-mask-114da307 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-25-to-29-may-2026-1ed9fa53 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-catheter-introducer-kit-issue-from-abiomed-97561092 2026-06-02 monthly 0.6 https://platform.ontopharmatech.com/news/pharmacovigilance-related-regulatory-recommendations-for-centrally-authorised-ve-0933567e 2026-06-01 monthly 0.6 https://platform.ontopharmatech.com/news/united-for-health-ema-in-worldpride-2026-68988e8f 2026-05-31 monthly 0.6 https://platform.ontopharmatech.com/news/decision-medical-devices-given-exceptional-use-authorisations-624a4b9f 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/two-arrested-during-the-mhra-s-largest-ever-seizure-of-unlicensed-weight-loss-me-12e0d837 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/relay-pro-thoracic-stent-graft-system-84893ed2 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/omnipod-insulin-management-system-omnipod-94e62929 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/hizentra-the-appearance-is-out-of-specification-in-the-affected-lot-5dbcef34 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/etf-recommends-updating-covid-19-vaccines-to-target-xfg-variant-a2a6df90 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/rilzabrutinib-authorised-to-treat-adults-with-immune-thrombocytopenia-when-prior-582263b2 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/list-of-centrally-authorised-products-with-safety-related-changes-to-the-product-d6be3582 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/concept-paper-on-the-need-for-revision-of-the-guideline-on-the-development-of-me-14ec63f6 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/dexcom-uncovers-theft-of-scrapped-product-notifies-potentially-impacted-users-ea907ad2 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/pediatric-care-bed-correction-kayserbetten-issues-correction-for-kayserbett-ida--bf1a5487 2026-05-29 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-18-22-may-2026-91f842e8 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/product-management-services-pms-implementation-of-international-organization-for-05cd872f 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/precautionary-recall-of-blood-pressure-medication-crescent-pharma-limited-ramipr-e07055a4 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/class-2-medicines-recall-crescent-pharma-limited-ramipril-2-5-mg-capsules-el-26--1e75b30b 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-safety-roundup-may-2026-8bb1e707 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/ge-healthcare-aw-server-40bab407 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/hamilton-medical-ag-breathing-set-mri-efab03da 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/gore-tag-thoracic-branch-endoprosthesis-side-branch-component-f1db351a 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/ventilator-correction-philips-issues-correction-for-trilogy-evo-platform-ventila-b2c3f3e4 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/cryoprobe-recall-erbe-usa-removes-flexible-cryoprobes-d2e50f69 2026-05-28 monthly 0.6 https://platform.ontopharmatech.com/news/allurion-gastric-balloon-updated-safety-information-due-to-the-risks-of-gastric--dd237927 2026-05-27 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-welcomes-jason-bonander-as-he-starts-his-role-as-chief-digital-and-technolo-d2c56017 2026-05-27 monthly 0.6 https://platform.ontopharmatech.com/news/eu-recommendations-for-2026-2027-seasonal-flu-vaccine-composition-95f23ea4 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/second-amended-biologics-working-party-vaccines-quality-operational-expert-group-90411b1b 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/amended-biologics-working-party-vaccines-quality-operational-expert-group-bv-oeg-ac04d185 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/don-t-let-this-heatwave-affect-your-medicines-three-important-tips-from-the-mhra-e899be48 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/dialysis-catheter-kit-recall-arrow-international-removes-dialysis-catheter-kits--bea9881b 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/manifold-recall-medline-removes-namic-star-off-handle-manifolds-7c76d321 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/insulet-initiates-voluntary-medical-device-correction-for-certain-omnipod-pods-i-e9c5a466 2026-05-26 monthly 0.6 https://platform.ontopharmatech.com/news/sahpra-and-the-sapc-crack-down-on-unlawful-manufacturing-of-unregistered-glp-1-g-b8ddc516 2026-05-23 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-mhra-performance-data-6366ab1e 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/questions-and-answers-on-periodic-safety-update-report-single-assessment-psusa-g-8f1e4e66 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/guideline-on-good-pharmacovigilance-practices-gvp-module-vii-periodic-safety-upd-d5196f0c 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-veterinary-medicinal-products-cvmp-19--57f2a0fb 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/merlin-3650-patient-care-system-pcs-96ec0f56 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/gsp-neonatal-galt-kit-78b0cfe9 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/red-rubber-latex-catheters-ba496803 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/meeting-highlights-from-the-committee-for-medicinal-products-for-human-use-chmp--372ecf09 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/new-medicine-for-two-types-of-pulmonary-fibrosis-165c5ee1 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/project-orbis-66e1e55d 2026-05-22 monthly 0.6 https://platform.ontopharmatech.com/news/decision-suspended-and-revoked-licences-and-registrations-for-manufacturers-and--25d7d043 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/decision-human-medicines-register-of-electronic-export-certificates-bd23bae1 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/lifepak-15-v4-spco-spmet-sensors-93acea95 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/neurological-sponges-0ca632b2 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/kirkland-signature-women-50-may-contain-the-presence-of-foreign-matter-metal-fra-4357c4bc 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/ema-closed-on-whit-monday-25-may-09741310 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/cincinnati-surgical-branded-blades-and-scalpels-aa8dab4c 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-on-the-details-of-the-classification-of-variations-requiring-assessment-e7e23921 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/early-alert-heart-pump-controller-issue-from-abiomed-132c70f2 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/automated-compounding-system-recall-omnicell-removes-syringe-labels-used-with-th-46865023 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/ventilator-recall-react-health-removes-vocsn-v-pro-ventilators-95256843 2026-05-21 monthly 0.6 https://platform.ontopharmatech.com/news/draft-rare-disease-therapies-regulatory-framework-57ac3ba5 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/landmark-new-plans-bring-treatments-for-rare-diseases-a-step-closer-310fcaa2 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-consults-on-new-regulatory-framework-to-make-uk-a-global-leader-in-rare-dis-ab55da32 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/amiodarone-reminder-of-risks-of-treatment-and-need-for-patient-monitoring-and-su-96165b15 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/risk-of-severe-harm-from-use-of-incorrect-giving-administration-set-for-blood-tr-eae7427a 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/eu-tracks-progress-towards-2030-clinical-trial-targets-70ada5f5 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/corporate-report-mhra-nice-real-world-evidence-scientific-dialogue-984df2a0 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/thoracic-stent-graft-recall-bolton-medical-removes-relay-pro-system-a504f753 2026-05-20 monthly 0.6 https://platform.ontopharmatech.com/news/kimal-procedure-packs-containing-recalled-components-namic-angiographic-syringe--36ec301c 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/field-safety-notices-11-to-15-may-2026-de63c025 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/guidance-innovative-licensing-and-access-pathway-ilap-ae18eaa4 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/international-council-for-harmonisation-of-technical-requirements-for-pharmaceut-f7f49161 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/transparency-data-medicines-and-healthcare-products-regulatory-agency-spending-o-57d6cc70 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/clinical-investigations-for-medical-devices-5d63afb7 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/decision-marketing-authorisations-granted-in-2026-64c02122 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/decision-parallel-import-licences-granted-in-2026-c42c7a7a 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-to-support-local-life-sciences-sector-in-wales-8b5f4955 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/blood-glucose-monitor-recall-trividia-health-issues-correction-for-true-metrix-b-9b66139d 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/risks-of-using-true-metrix-blood-glucose-monitoring-systems-by-trividia-health-f-f415f3ff 2026-05-19 monthly 0.6 https://platform.ontopharmatech.com/news/decision-orphan-registered-medicinal-products-8da7e47f 2026-05-18 monthly 0.6 https://platform.ontopharmatech.com/news/professor-joann-rhodes-the-rules-need-to-bend-why-flexible-policies-and-real-par-f01f233d 2026-05-18 monthly 0.6 https://platform.ontopharmatech.com/news/mhra-approves-beremagene-geperpavec-vyjuvek-for-the-treatment-of-dystrophic-epid-97f8686f 2026-05-15 monthly 0.6